PCMF
DGX icon

Private Capital Management (Florida)’s Quest Diagnostics DGX Stock Holding History

Private Capital Management (Florida)’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,000
Closed -$1.55M – 69
2020
Q4 		$1.55M Buy
+13,000
New +$1.58M 0.29% 33

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Private Capital Management (Florida)'s DGX Position: Q1 2026 in Review

Private Capital Management (Florida) held its Quest Diagnostics (DGX) position steady in Q1 2026 at 8,700 shares worth $1.71M. The position accounts for 0.17% of the portfolio, ranked #78.

Private Capital Management (Florida) first reported a position in DGX in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.76M in Q1 2025. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Private Capital Management (Florida) held 8,700 shares of Quest Diagnostics worth $1.71M as of Q1 2026.
  • Private Capital Management (Florida) left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up 0.17% of Private Capital Management (Florida)'s portfolio in Q1 2026, its #78 holding.
  • Private Capital Management (Florida) first reported a position in Quest Diagnostics in Q3 2022 and has held it in 15 quarters since.
  • Private Capital Management (Florida)'s Quest Diagnostics position peaked at $1.76M in Q1 2025.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Private Capital Management (Florida)'s 13F filing for Q1 2026, filed 15 May 2026.